Salute e Benessere

Multicancer Screening Market Projected to Reach $2.72 billion by 2030 -…

Using revolutionary advances in liquid biopsies, genetic testing, and artificial intelligence (AI), multi-cancer screening emerges as a pivotal breakthrough in oncology research, offering an exceptional ability to identify various cancers, such as lung, breast, colorectal, and prostate. This innovative approach significantly improves patient outcomes by facilitating timely and more effective treatment paths. Fuelled by a surge in global cancer rates and increased awareness of the benefits of…
PR Newswire
16/04/2024

Nebulizer Market Projected to Reach $3.97 billion by 2030 - Exclusive Report by…

Nebulizers play a crucial role by converting liquid medications into fine mists and facilitating direct inhalation into the lungs, as this is a vital instrument in managing respiratory ailments such as asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, and other lung conditions. This medication delivery method ensures efficient absorption and aids in rapid symptom relief for individuals requiring pulmonary treatment. The prevalence of respiratory disorders, attributed to…
PR Newswire
16/04/2024

LG OFFERS EXTRAORDINARY LIFESTYLE EXPERIENCE IN COLLABORATION WITH MOOOI AT…

A Must-see Exhibition: Innovative in Home Appliances as Objet d'Art A Must-see Exhibition: Innovative in Home Appliances as Objet d'Art Moooi's "creative luxury" is immediately apparent in each engaging and elegant display that makes up the memorable exhibit. The Dutch company's curated furniture pieces, lightings, patterns and interior accessories are perfectly paired with a wide range of stylish, premium LG appliances. Among these are the PuriCare™️ AeroFurniture, InstaView™...
PR Newswire
16/04/2024

KONKA Shines at 2024 Canton Fair with Cutting-Edge Home Appliances Products

KONKA also turned heads with its ultra-thin refrigerator that boasts just a mere width of 700mm. This design not only enhances kitchen aesthetics but also frees up valuable cooking space, addressing common spatial challenges faced by modern households. KONKA also turned heads with its ultra-thin refrigerator that boasts just a mere width of 700mm. This design not only enhances kitchen aesthetics but also frees up valuable cooking space, addressing common spatial challenges faced by modern...
PR Newswire
16/04/2024

CAR T-Cell Therapy for Non-Hodgkin's Lymphoma Market to Showcase Significant…

Key Takeaways from the CAR T-Cell Therapy for Non-Hodgkin's Lymphoma Market Report Key Takeaways from the CAR T-Cell Therapy for Non-Hodgkin's Lymphoma Market Report Discover which therapies are expected to grab the major CAR T-Cell therapy for NHL market share @ CAR T-Cell Therapy for NHL Market Report CAR T-Cell Therapy for Non-Hodgkin's Lymphoma Overview CAR-T cell therapy represents a groundbreaking advancement in cancer immunotherapy, especially for specific types of NHL...
PR Newswire
15/04/2024

GENFIT Annual Combined General Meeting of May 22, 2024 — Availability of…

Lille (France); Cambridge (Massachusetts, United States); Zurich (Switzerland); April 15, 2024-GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announced that it published in the April 15, 2024 French legal announcements bulletin n°46 ( Bulletin des Annonces Légales Obligatoires ) its convening notice that the Combined Shareholders Meeting will be held on May 22,...
Nasdaq GlobeNewswire
15/04/2024

Change in the number of shares and votes in Beyond Frames Entertainment AB…

CONTACT: CONTACT: For further information, please contact: ir@beyondframes.com +46 (0)72 842 49 22 This information was brought to you by Cisionhttp://news.cision.com https://news.cision.com/beyond-frames/r/change-in-the-number-of-shares-and-votes-in-beyond-frames-entertainment-ab--publ-,c3961887 The following files are available for download: View original content:...
PR Newswire
15/04/2024

New Novartis Fabhalta® (iptacopan) data show clinically meaningful and…

APPLAUSE-IgAN is first and only Phase III study to demonstrate significant proteinuria reduction by targeting the complement system in patients with IgAN 1 IgAN is a heterogeneous, progressive, rare kidney disease and is a major cause of chronic kidney disease worldwide 2 ; complement activation is a key driver of glomerular inflammation in IgAN 3,4 There is a need for effective, targeted therapies for IgAN 2,5 ; up to 30% of patients with persistent proteinuria (≥1...
Nasdaq GlobeNewswire
15/04/2024

Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives…

Bagsværd, Denmark, 15 April 2024— This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company's board members, executives and their associated persons in accordance with Article 19 of Regulation No. 596/2014 on market abuse. The company's board members, executives and their associated persons have reported the transactions to Novo Nordisk and have given Novo Nordisk power of attorney on their behalf to publish trading in Novo Nordisk...
Nasdaq GlobeNewswire
15/04/2024

Publication Annual Report – Annual Shareholders' Meeting

Publication Annual Report – Annual Shareholders' MeetingLeuven, BELGIUM – April 15, 2024 – 05:00 PM CETOxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, has today published its annual report for the financial year 2023. The annual report for the year ending December 31, 2023 is available in the “Investors” section of the Company's website, and can also be downloaded as a PDF.On this day as well, the Company has convened its Annual Shareholders'...
Nasdaq GlobeNewswire
15/04/2024

Craniofacial Implants Market to reach $118.2 million, Globally, by 2032 at 8.3%…

Request Sample of the Report on Craniofacial Implants Market Forecast - https://www.alliedmarketresearch.com/request-sample/A295583 Request Sample of the Report on Craniofacial Implants Market Forecast -https://www.alliedmarketresearch.com/request-sample/A295583 Prime determinants of growth The craniofacial implants market has experienced significant growth owing to technological advancements in the craniofacial implant technology, rise in incidence of facial fractures due to...
PR Newswire
15/04/2024

Core Clinical Molecular Diagnostics Market to Reach $11.9 Billion, Globally, by…

Request Sample of the Report on Core Clinical Molecular Diagnostics Market Forecast - https://www.alliedmarketresearch.com/request-sample/A323203 Request Sample of the Report on Core Clinical Molecular Diagnostics Market Forecast -https://www.alliedmarketresearch.com/request-sample/A323203 Prime determinants of growth Growth in the adoption of molecular diagnostics, advancements in technologies, and presence of key players are the factors that drive the growth of the global core...
PR Newswire
15/04/2024

Norgine B.V. submits Marketing Authorisation Application via Project Orbis for…

On 13 December 2023, the US Food and Drug Administration (FDA) approved eflornithine as the first oral maintenance therapy for high-risk neuroblastoma (HRNB), indicated to reduce the risk of relapse in adult and paediatric patients who have received certain prior therapies.1 The approval decision was based on findings from a trial comparing outcomes from Study 3b (NCT02395666; investigational arm)2,4 and Study ANBL0032 (NCT00026312; clinical-trial-derived external control arm)3,4, where use of…
PR Newswire
15/04/2024

Robotic Radiotherapy Market Worth $1.9 billion | MarketsandMarkets™

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=122256158 Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=122256158 Browse in-depth TOC on "Robotic Radiotherapy Market" 180 - Tables45 - Figures270 - Pages Robotic Radiotherapy Market Scope: The 3D cameras (SGRT) segment is expected to register the highest growth in the forecast period of 2023-2028. Based on the product, the...
PR Newswire
15/04/2024

Body Mist Market to Reach $12.6 billion, Globally, by 2032 at 5.2% CAGR: Allied…

Prime determinants of growth Prime determinants of growth The burgeoning emphasis on wellness and self-care routines has become an important aspect of contemporary lifestyles, thus driving the demand for products that cater to holistic well-being. Body mists, with their refreshing fragrances and therapeutic benefits, have emerged as a favored choice among consumers seeking moments of relaxation and rejuvenation amid their busy schedules. On the other hand, diversifying the product range...
PR Newswire
15/04/2024

89th CMEF in Shanghai Elevates Global Medical Device Trade to The Next Level

This year, the exhibition featured nearly 5,000 renowned global enterprises with flagship products on display. Diverse categories were designed to explore emerging trends and prospects. Key categories include: This year, the exhibition featured nearly 5,000 renowned global enterprises with flagship products on display. Diverse categories were designed to explore emerging trends and prospects. Key categories include: This year, CMEF kicked off onApril 11th, coinciding with World...
PR Newswire
15/04/2024

Novo Nordisk A/S - share repurchase programme

Bagsværd, Denmark, 15 April 2024– On 6 February 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 20 billion to be executed during a 12-month period beginning 6 February 2024. Under the...
Nasdaq GlobeNewswire
15/04/2024

135th Canton Fair Opens with Optimized Structure and Enhanced Global Trade…

The 135th Canton Fair has kicked off with great enthusiasm. For the latest information on this session of the Canton Fair, please register at https://invitation.cantonfair.org.cn/BuyerUser/RegisterUser?MediaType=16. The 135 thCanton Fair has kicked off with great enthusiasm. For the latest information on this session of the Canton Fair, please register athttps://invitation.cantonfair.org.cn/BuyerUser/RegisterUser?MediaType=16. Photo -...
PR Newswire
15/04/2024

London Research & Pharmaceuticals presents the advancement of LRP-661, their…

When compared against the currently available oral solution of cannabidiol in a sesame oil suspension, CBDS shows no effect on gastrointestinal tolerability (no diarrhea) and no weight loss in animals, as well as no liver or renal toxicity and low affinity for many CYP-450 isozymes (such as 1A2, 3A4, 2B6) or P-glycoprotein (P-GP), which are responsible for many adverse drug-drug interactions.CBDS demonstrates high activity in several preclinical epilepsy models in which seizures are...
Nasdaq GlobeNewswire
15/04/2024

Akari Therapeutics to Present PAS-Nomacopan Pre-Clinical Electroretinography…

BOSTON and LONDON, April15, 2024(GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, today announced the company will present new pre-clinical data on investigational long-acting PAS-nomacopan including drug effect on electroretinography (ERG) testing in a blue light model at the upcoming Association for Research in Vision and Ophthalmology (ARVO) 2024 Annual Meeting in Seattle. Akari...
Nasdaq GlobeNewswire
15/04/2024

LG TARGETS EUROPEAN Built-in MARKET AT MILAN DESIGN WEEK 2024

Since the launch of its ultra-premium Signature Kitchen Suite built-in appliances, LG has continuously and strategically expanded its presence around the globe. Last year's IFA exhibition in Germany marked the introduction of the built-in lineups from LG brand, which complement the company's well-established ultra-premium offerings. At Milan Design Week 2024, the company seeks to demonstrate its commitment to providing premier culinary lifestyles, with a diverse range of products designed to…
PR Newswire
15/04/2024

Invitation: Sobi's Q1 2024 report

The presentation can be followed live here or afterwards on sobi.com. The slides will be made available on sobi.com prior to the conference call. The presentation can be followed livehereor afterwards on sobi.com. The slides will be made available on sobi.com prior to the conference call. To participate in the conference call, please use the following dial-in details:Sweden : +46 8 5051 0031United Kingdom : +44 207 107 06 13United States : +1 631 570 56 13 For other countries,...
PR Newswire
15/04/2024

Transactions in Connection with Share Buy-back Program Genmab

Company Announcement COPENHAGEN, Denmark; April 15, 2024 – Genmab A/S (Nasdaq: GMAB).On March 15, 2024, Genmab announced the initiation of a share buy-back program to repurchase up to DKK 3.5 billion worth of shares.The share buy-back program is expected to be completed no later than December 16, 2024.The following transactions were executed under the program from April 8, 2024 to April 12, 2024: Trading PlatformNo. of sharesAverage price (DKK)Total value (DKK)...
Nasdaq GlobeNewswire
15/04/2024

Gedeon Richter: Cariprazine shows effectiveness in the treatment for dual…

In addition, Richter organized two scientific sessions: the Product Theatre focused on the topic of "New treatment options for dual schizophrenia", and a Mini Symposium was organized on the topic of "Schizophrenia and the management of psychiatric comorbidities", such as affective, anxiety and substance use disorders. In addition, Richter organized two scientific sessions: the Product Theatre focused on the topic of " New treatment options for dual schizophrenia "…
PR Newswire
15/04/2024
Altri  Comunicati